pandemic influenza vaccine (H5N1 strain NIBRG-14)
PRO-PanFlu-2001
Phase 2 mab completed
Quick answer
pandemic influenza vaccine (H5N1 strain NIBRG-14) for Pandemic Influenza is a Phase 2 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- Pandemic Influenza
- Phase
- Phase 2
- Modality
- mab
- Status
- completed